Latest Capital Raises News

Comet Ridge has made significant strides in its Mahalo Gas Hub development, approving upstream FEED and progressing pipeline connections, supported by a strong cash position of $19.3 million. These developments position the company to address Australia's tightening east coast gas market.

Botala Energy has secured critical environmental approvals for its Serowe CBM Project and successfully raised A$1.87 million, positioning the company for commercial gas production in Southern Africa.

Golden Horse Minerals has successfully listed on the ASX, raising A$18 million to fund exploration across a consolidated 130km strike in Western Australia's Southern Cross Greenstone Belt. The company is gearing up for a major drilling campaign at the historic Hopes Hill gold mine.

Mesoblast Limited is set to launch Ryoncil®, the first FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease, backed by a recent $160 million financing that strengthens its commercial and clinical development efforts.

Titan Minerals has made significant strides in its Ecuadorian copper and gold projects, securing a $20 million capital raise and progressing key drilling milestones under a major joint venture agreement.

Coda Minerals has significantly enhanced the economic outlook of its Elizabeth Creek Copper-Cobalt Project, with a pre-tax NPV7 rising to $1.18 billion and a post-tax NPV7 increase of 57% to $802 million. The company also secured $5.1 million in fresh capital to accelerate exploration and drilling activities in 2025.

Arika Resources has expanded its exploration footprint at the Yundamindra Gold Project with over 25 new high-priority gold targets identified and a $3.2 million capital raise to fast-track drilling programs. The company awaits assay results from recent drilling that could redefine the project's scale.

Core Energy Minerals Ltd has fortified its uranium exploration ambitions with a $3.7 million capital raise and strategic acquisitions in South Australia, setting the stage for a busy 2025 exploration calendar.

Osteopore Limited reports a robust 27% year-over-year revenue increase despite operational headwinds, underpinned by new collaborations in stem cell therapies and expanded market access in Brazil and Singapore.

Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.

QEM Limited has marked significant progress in its Julia Creek Vanadium and Energy Project, securing key government approvals and raising $2.76 million to advance development and environmental studies.

Atrum Coal Limited reported a $1.25 million net cash outflow for the December 2024 quarter, driven by exploration and litigation expenses, while successfully raising $5.8 million through an equity entitlement issue.